Online Only Articles

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma

Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France;Hospices Civils de Lyon, France;ProfileXpert, Lyon, France
Institut Gustave Roussy, Villejuif, France
Hematology, Centre Léon Bérard, UMR 5239 CNRS, Lyon, France
GELA-RC, Hospices Civils de Lyon, Pierre Bénite, France
Hematology, Necker Hospital, Paris, France
Centre Henri Becquerel, Rouen, France
Hematology, Hôpital Henri Mondor, Créteil, France
Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France
Hospices Civils de Lyon, France;ProfileXpert, Lyon, France
Hospices Civils de Lyon, Centre Hospitalier Universitaire Lyon-Sud, Hématologie, Université Lyon 1, UMR 5239 CNRS, France
Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France;Hospices Civils de Lyon, France;ProfileXpert, Lyon, France;Laboratory of Hematology, Hospices Civils de Lyon, Pierre-Bénite, France
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.120113